Which pricing strategy did Novartis pioneer in 2001 that revolutionized access to cancer treatment in low-income countries?

In recent years, pharmaceutical companies have implemented various pricing strategies to balance profitability with accessibility. One revolutionary approach dramatically changed how certain life-saving medications are priced in developing markets. Test your knowledge of pharmaceutical business innovation and how one company's strategy became an industry benchmark for ethical pricing in global healthcare.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Tiered pricing based on a country's GDP
Buy-one-give-one model for all oncology drugs
Subscription-based medication access
Outcome-based pricing with refunds for non-responders